Acceptability of Testing DNA Markers in Vaginal Fluid for the Detection of Endometrial Cancer
ConditionEndometrial Carcinoma
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age45+
SponsorMayo Clinic
About this trial
This study evaluates how women feel about using DNA from a vaginal fluid collection for early detection of endometrial cancer.
Eligibility criteria
Qualifiers
Self-identified Black individuals ≥ 45 years with an intact uterus
Assigned female sex at birth
Experience with abnormal uterine or post-menopausal bleeding (defined as vaginal bleeding between periods, heavy vaginal bleeding, vaginal bleeding after menopause, and/or red, brown, or pink colored vaginal discharge after menopause)
Willing to participate in a 45-minute virtual interview
Disqualifiers
Previous or current diagnosis of endometrial cancer
Trial design
Treatments tested in this trial
- Non-Interventional Study
Treatment groups
25 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov